PATECATL PHARMACEUTICALS PRIVATE LIMITED
PATECATL PHARMACEUTICALS PRIVATE LIMITED is a DELHI based PRIVATE LIMITED company, Registered at dated 22-JUL-2024 on Ministry of Corporate Affairs(MCA), The Corporate Identification Number (CIN) of PATECATL PHARMACEUTICALS PRIVATE LIMITED is U21002DL2024PTC434410 and registration number is 434410.
It has been classified as COMPANY LIMITED BY SHARES and is registered under Registar of Companies ROC DELHI India. Authorized share capital of PATECATL PHARMACEUTICALS PRIVATE LIMITED is Rs. 1000000 and its paid up capital is Rs. 200000. It aspire to serve in NA activities across the India.
Its Annual General Meeting (AGM) was lastly conducted on and as per the records of Ministry of Corporate Affairs (MCA), its balance sheet was last filed on .
PATECATL PHARMACEUTICALS PRIVATE LIMITED has 2 directors UTKARSH JAISWAL, MANORAMA DEVI,
The registered Email address of PATECATL PHARMACEUTICALS PRIVATE LIMITED is sun.rakeshjaiswal@gmail.com and its registered address is HOUSE NO 168, FLOOR 1ST LANDMARK NEAR CHAR KHAMBA SHAKUR PURI BLOCK DELHI NORTH WEST DELHI DL 110034 IN DELHI DELHI india 110034.
The current status of PATECATL PHARMACEUTICALS PRIVATE LIMITED shows as ACTIVE
COMPANY BASIC DETAILS
PATECATL PHARMACEUTICALS PRIVATE LIMITED
ROC DELHI
ACTIVE
U21002DL2024PTC434410
22-JUL-2024
COMPANY LIMITED BY SHARES
NON-GOVT COMPANY
PRIVATE
1000000
200000
CONTACT DETAILS
110034
INDIA
HOUSE NO 168, FLOOR 1ST LANDMARK NEAR CHAR KHAMBA SHAKUR PURI BLOCK DELHI NORTH WEST DELHI DL 110034 IN
sun.rakeshjaiswal@gmail.com
DIRECTOR DETAILS
DIN | Director Name | Designation | Appointment Date |
---|---|---|---|
10714513 | UTKARSH JAISWAL | Director | 22/07/2024 |
10714514 | MANORAMA DEVI | Director | 22/07/2024 |
Details Updated by Companies
Quick Links
- All Registered company of DELHI
- Company Registered in DELHI
- All Registered company of NORTH WEST DELHI in DELHI
- Listed Company
- Company Category
- Latest Registered Company
Contact Us for Update Extra Information about your company and services.